The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hematology Oncology Diagnostics Market Research Report 2025
Synopsis
Physicians use a variety of tests to accurately diagnose cancer, determine prognosis, and monitor cancer for progression and side effects.
The global Hematology Oncology Diagnostics market was valued at US$ 2572.8 million in 2023 and is anticipated to reach US$ 4366.3 million by 2030, witnessing a CAGR of 8.1% during the forecast period 2024-2030.
The Hematology Oncology Diagnostics market has seen substantial growth due to increasing cancer prevalence, advancements in diagnostic technologies, and a growing emphasis on early disease detection.
This report aims to provide a comprehensive presentation of the global market for Hematology Oncology Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Oncology Diagnostics.
Report Scope
The Hematology Oncology Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hematology Oncology Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematology Oncology Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Roche
QIAGEN
Thermo Fisher Scientific
Illumina
Bio-Rad
ArcherDX
ARUP Laboratories
Asuragen
Invivoscribe
Adaptive Biotechnologies
Amoy Diagnostics
ELITechGroup
Vela Diagnostics
Gentronix
BioIVT
SAGA Diagnostics
Berry Genomics
Segment by Type
PCR
IHC
NGS
Cytogenetics
Others
Segment by Application
Clinical Laboratories
Hospitals
Research Institutes
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematology Oncology Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Physicians use a variety of tests to accurately diagnose cancer, determine prognosis, and monitor cancer for progression and side effects.
The global Hematology Oncology Diagnostics market was valued at US$ 2572.8 million in 2023 and is anticipated to reach US$ 4366.3 million by 2030, witnessing a CAGR of 8.1% during the forecast period 2024-2030.
The Hematology Oncology Diagnostics market has seen substantial growth due to increasing cancer prevalence, advancements in diagnostic technologies, and a growing emphasis on early disease detection.
This report aims to provide a comprehensive presentation of the global market for Hematology Oncology Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Oncology Diagnostics.
Report Scope
The Hematology Oncology Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hematology Oncology Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematology Oncology Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Roche
QIAGEN
Thermo Fisher Scientific
Illumina
Bio-Rad
ArcherDX
ARUP Laboratories
Asuragen
Invivoscribe
Adaptive Biotechnologies
Amoy Diagnostics
ELITechGroup
Vela Diagnostics
Gentronix
BioIVT
SAGA Diagnostics
Berry Genomics
Segment by Type
PCR
IHC
NGS
Cytogenetics
Others
Segment by Application
Clinical Laboratories
Hospitals
Research Institutes
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hematology Oncology Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hematology Oncology Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 PCR
1.2.3 IHC
1.2.4 NGS
1.2.5 Cytogenetics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hematology Oncology Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Laboratories
1.3.3 Hospitals
1.3.4 Research Institutes
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hematology Oncology Diagnostics Market Perspective (2019-2030)
2.2 Hematology Oncology Diagnostics Growth Trends by Region
2.2.1 Global Hematology Oncology Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hematology Oncology Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Hematology Oncology Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Hematology Oncology Diagnostics Market Dynamics
2.3.1 Hematology Oncology Diagnostics Industry Trends
2.3.2 Hematology Oncology Diagnostics Market Drivers
2.3.3 Hematology Oncology Diagnostics Market Challenges
2.3.4 Hematology Oncology Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hematology Oncology Diagnostics Players by Revenue
3.1.1 Global Top Hematology Oncology Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Hematology Oncology Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Hematology Oncology Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hematology Oncology Diagnostics Revenue
3.4 Global Hematology Oncology Diagnostics Market Concentration Ratio
3.4.1 Global Hematology Oncology Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hematology Oncology Diagnostics Revenue in 2023
3.5 Hematology Oncology Diagnostics Key Players Head office and Area Served
3.6 Key Players Hematology Oncology Diagnostics Product Solution and Service
3.7 Date of Enter into Hematology Oncology Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hematology Oncology Diagnostics Breakdown Data by Type
4.1 Global Hematology Oncology Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Hematology Oncology Diagnostics Forecasted Market Size by Type (2025-2030)
5 Hematology Oncology Diagnostics Breakdown Data by Application
5.1 Global Hematology Oncology Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Hematology Oncology Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hematology Oncology Diagnostics Market Size (2019-2030)
6.2 North America Hematology Oncology Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hematology Oncology Diagnostics Market Size by Country (2019-2024)
6.4 North America Hematology Oncology Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hematology Oncology Diagnostics Market Size (2019-2030)
7.2 Europe Hematology Oncology Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hematology Oncology Diagnostics Market Size by Country (2019-2024)
7.4 Europe Hematology Oncology Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hematology Oncology Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Hematology Oncology Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hematology Oncology Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Hematology Oncology Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hematology Oncology Diagnostics Market Size (2019-2030)
9.2 Latin America Hematology Oncology Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hematology Oncology Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Hematology Oncology Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hematology Oncology Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Hematology Oncology Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hematology Oncology Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Hematology Oncology Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Hematology Oncology Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Hematology Oncology Diagnostics Introduction
11.2.4 Roche Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.2.5 Roche Recent Development
11.3 QIAGEN
11.3.1 QIAGEN Company Detail
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN Hematology Oncology Diagnostics Introduction
11.3.4 QIAGEN Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.3.5 QIAGEN Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Hematology Oncology Diagnostics Introduction
11.4.4 Thermo Fisher Scientific Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Illumina
11.5.1 Illumina Company Detail
11.5.2 Illumina Business Overview
11.5.3 Illumina Hematology Oncology Diagnostics Introduction
11.5.4 Illumina Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.5.5 Illumina Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad Hematology Oncology Diagnostics Introduction
11.6.4 Bio-Rad Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.6.5 Bio-Rad Recent Development
11.7 ArcherDX
11.7.1 ArcherDX Company Detail
11.7.2 ArcherDX Business Overview
11.7.3 ArcherDX Hematology Oncology Diagnostics Introduction
11.7.4 ArcherDX Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.7.5 ArcherDX Recent Development
11.8 ARUP Laboratories
11.8.1 ARUP Laboratories Company Detail
11.8.2 ARUP Laboratories Business Overview
11.8.3 ARUP Laboratories Hematology Oncology Diagnostics Introduction
11.8.4 ARUP Laboratories Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.8.5 ARUP Laboratories Recent Development
11.9 Asuragen
11.9.1 Asuragen Company Detail
11.9.2 Asuragen Business Overview
11.9.3 Asuragen Hematology Oncology Diagnostics Introduction
11.9.4 Asuragen Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.9.5 Asuragen Recent Development
11.10 Invivoscribe
11.10.1 Invivoscribe Company Detail
11.10.2 Invivoscribe Business Overview
11.10.3 Invivoscribe Hematology Oncology Diagnostics Introduction
11.10.4 Invivoscribe Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.10.5 Invivoscribe Recent Development
11.11 Adaptive Biotechnologies
11.11.1 Adaptive Biotechnologies Company Detail
11.11.2 Adaptive Biotechnologies Business Overview
11.11.3 Adaptive Biotechnologies Hematology Oncology Diagnostics Introduction
11.11.4 Adaptive Biotechnologies Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.11.5 Adaptive Biotechnologies Recent Development
11.12 Amoy Diagnostics
11.12.1 Amoy Diagnostics Company Detail
11.12.2 Amoy Diagnostics Business Overview
11.12.3 Amoy Diagnostics Hematology Oncology Diagnostics Introduction
11.12.4 Amoy Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.12.5 Amoy Diagnostics Recent Development
11.13 ELITechGroup
11.13.1 ELITechGroup Company Detail
11.13.2 ELITechGroup Business Overview
11.13.3 ELITechGroup Hematology Oncology Diagnostics Introduction
11.13.4 ELITechGroup Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.13.5 ELITechGroup Recent Development
11.14 Vela Diagnostics
11.14.1 Vela Diagnostics Company Detail
11.14.2 Vela Diagnostics Business Overview
11.14.3 Vela Diagnostics Hematology Oncology Diagnostics Introduction
11.14.4 Vela Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.14.5 Vela Diagnostics Recent Development
11.15 Gentronix
11.15.1 Gentronix Company Detail
11.15.2 Gentronix Business Overview
11.15.3 Gentronix Hematology Oncology Diagnostics Introduction
11.15.4 Gentronix Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.15.5 Gentronix Recent Development
11.16 BioIVT
11.16.1 BioIVT Company Detail
11.16.2 BioIVT Business Overview
11.16.3 BioIVT Hematology Oncology Diagnostics Introduction
11.16.4 BioIVT Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.16.5 BioIVT Recent Development
11.17 SAGA Diagnostics
11.17.1 SAGA Diagnostics Company Detail
11.17.2 SAGA Diagnostics Business Overview
11.17.3 SAGA Diagnostics Hematology Oncology Diagnostics Introduction
11.17.4 SAGA Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.17.5 SAGA Diagnostics Recent Development
11.18 Berry Genomics
11.18.1 Berry Genomics Company Detail
11.18.2 Berry Genomics Business Overview
11.18.3 Berry Genomics Hematology Oncology Diagnostics Introduction
11.18.4 Berry Genomics Revenue in Hematology Oncology Diagnostics Business (2019-2024)
11.18.5 Berry Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Hematology Oncology Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of PCR
Table 3. Key Players of IHC
Table 4. Key Players of NGS
Table 5. Key Players of Cytogenetics
Table 6. Key Players of Others
Table 7. Global Hematology Oncology Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Hematology Oncology Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Hematology Oncology Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Hematology Oncology Diagnostics Market Share by Region (2019-2024)
Table 11. Global Hematology Oncology Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Hematology Oncology Diagnostics Market Share by Region (2025-2030)
Table 13. Hematology Oncology Diagnostics Market Trends
Table 14. Hematology Oncology Diagnostics Market Drivers
Table 15. Hematology Oncology Diagnostics Market Challenges
Table 16. Hematology Oncology Diagnostics Market Restraints
Table 17. Global Hematology Oncology Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Hematology Oncology Diagnostics Market Share by Players (2019-2024)
Table 19. Global Top Hematology Oncology Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematology Oncology Diagnostics as of 2023)
Table 20. Ranking of Global Top Hematology Oncology Diagnostics Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Hematology Oncology Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hematology Oncology Diagnostics Product Solution and Service
Table 24. Date of Enter into Hematology Oncology Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hematology Oncology Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Hematology Oncology Diagnostics Revenue Market Share by Type (2019-2024)
Table 28. Global Hematology Oncology Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Hematology Oncology Diagnostics Revenue Market Share by Type (2025-2030)
Table 30. Global Hematology Oncology Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Hematology Oncology Diagnostics Revenue Market Share by Application (2019-2024)
Table 32. Global Hematology Oncology Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Hematology Oncology Diagnostics Revenue Market Share by Application (2025-2030)
Table 34. North America Hematology Oncology Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Hematology Oncology Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Hematology Oncology Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Hematology Oncology Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Hematology Oncology Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Hematology Oncology Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Hematology Oncology Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Hematology Oncology Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Hematology Oncology Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Hematology Oncology Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Hematology Oncology Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Hematology Oncology Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Hematology Oncology Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Hematology Oncology Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Hematology Oncology Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 49. Abbott Laboratories Company Detail
Table 50. Abbott Laboratories Business Overview
Table 51. Abbott Laboratories Hematology Oncology Diagnostics Product
Table 52. Abbott Laboratories Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 53. Abbott Laboratories Recent Development
Table 54. Roche Company Detail
Table 55. Roche Business Overview
Table 56. Roche Hematology Oncology Diagnostics Product
Table 57. Roche Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 58. Roche Recent Development
Table 59. QIAGEN Company Detail
Table 60. QIAGEN Business Overview
Table 61. QIAGEN Hematology Oncology Diagnostics Product
Table 62. QIAGEN Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 63. QIAGEN Recent Development
Table 64. Thermo Fisher Scientific Company Detail
Table 65. Thermo Fisher Scientific Business Overview
Table 66. Thermo Fisher Scientific Hematology Oncology Diagnostics Product
Table 67. Thermo Fisher Scientific Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 68. Thermo Fisher Scientific Recent Development
Table 69. Illumina Company Detail
Table 70. Illumina Business Overview
Table 71. Illumina Hematology Oncology Diagnostics Product
Table 72. Illumina Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 73. Illumina Recent Development
Table 74. Bio-Rad Company Detail
Table 75. Bio-Rad Business Overview
Table 76. Bio-Rad Hematology Oncology Diagnostics Product
Table 77. Bio-Rad Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 78. Bio-Rad Recent Development
Table 79. ArcherDX Company Detail
Table 80. ArcherDX Business Overview
Table 81. ArcherDX Hematology Oncology Diagnostics Product
Table 82. ArcherDX Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 83. ArcherDX Recent Development
Table 84. ARUP Laboratories Company Detail
Table 85. ARUP Laboratories Business Overview
Table 86. ARUP Laboratories Hematology Oncology Diagnostics Product
Table 87. ARUP Laboratories Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 88. ARUP Laboratories Recent Development
Table 89. Asuragen Company Detail
Table 90. Asuragen Business Overview
Table 91. Asuragen Hematology Oncology Diagnostics Product
Table 92. Asuragen Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 93. Asuragen Recent Development
Table 94. Invivoscribe Company Detail
Table 95. Invivoscribe Business Overview
Table 96. Invivoscribe Hematology Oncology Diagnostics Product
Table 97. Invivoscribe Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 98. Invivoscribe Recent Development
Table 99. Adaptive Biotechnologies Company Detail
Table 100. Adaptive Biotechnologies Business Overview
Table 101. Adaptive Biotechnologies Hematology Oncology Diagnostics Product
Table 102. Adaptive Biotechnologies Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 103. Adaptive Biotechnologies Recent Development
Table 104. Amoy Diagnostics Company Detail
Table 105. Amoy Diagnostics Business Overview
Table 106. Amoy Diagnostics Hematology Oncology Diagnostics Product
Table 107. Amoy Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 108. Amoy Diagnostics Recent Development
Table 109. ELITechGroup Company Detail
Table 110. ELITechGroup Business Overview
Table 111. ELITechGroup Hematology Oncology Diagnostics Product
Table 112. ELITechGroup Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 113. ELITechGroup Recent Development
Table 114. Vela Diagnostics Company Detail
Table 115. Vela Diagnostics Business Overview
Table 116. Vela Diagnostics Hematology Oncology Diagnostics Product
Table 117. Vela Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 118. Vela Diagnostics Recent Development
Table 119. Gentronix Company Detail
Table 120. Gentronix Business Overview
Table 121. Gentronix Hematology Oncology Diagnostics Product
Table 122. Gentronix Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 123. Gentronix Recent Development
Table 124. BioIVT Company Detail
Table 125. BioIVT Business Overview
Table 126. BioIVT Hematology Oncology Diagnostics Product
Table 127. BioIVT Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 128. BioIVT Recent Development
Table 129. SAGA Diagnostics Company Detail
Table 130. SAGA Diagnostics Business Overview
Table 131. SAGA Diagnostics Hematology Oncology Diagnostics Product
Table 132. SAGA Diagnostics Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 133. SAGA Diagnostics Recent Development
Table 134. Berry Genomics Company Detail
Table 135. Berry Genomics Business Overview
Table 136. Berry Genomics Hematology Oncology Diagnostics Product
Table 137. Berry Genomics Revenue in Hematology Oncology Diagnostics Business (2019-2024) & (US$ Million)
Table 138. Berry Genomics Recent Development
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hematology Oncology Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hematology Oncology Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. PCR Features
Figure 4. IHC Features
Figure 5. NGS Features
Figure 6. Cytogenetics Features
Figure 7. Others Features
Figure 8. Global Hematology Oncology Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Hematology Oncology Diagnostics Market Share by Application: 2023 VS 2030
Figure 10. Clinical Laboratories Case Studies
Figure 11. Hospitals Case Studies
Figure 12. Research Institutes Case Studies
Figure 13. Other Case Studies
Figure 14. Hematology Oncology Diagnostics Report Years Considered
Figure 15. Global Hematology Oncology Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Hematology Oncology Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Hematology Oncology Diagnostics Market Share by Region: 2023 VS 2030
Figure 18. Global Hematology Oncology Diagnostics Market Share by Players in 2023
Figure 19. Global Top Hematology Oncology Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematology Oncology Diagnostics as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Hematology Oncology Diagnostics Revenue in 2023
Figure 21. North America Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Hematology Oncology Diagnostics Market Share by Country (2019-2030)
Figure 23. United States Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Hematology Oncology Diagnostics Market Share by Country (2019-2030)
Figure 27. Germany Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Hematology Oncology Diagnostics Market Share by Region (2019-2030)
Figure 35. China Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Hematology Oncology Diagnostics Market Share by Country (2019-2030)
Figure 43. Mexico Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Hematology Oncology Diagnostics Market Share by Country (2019-2030)
Figure 47. Turkey Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Hematology Oncology Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Abbott Laboratories Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 50. Roche Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 51. QIAGEN Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 53. Illumina Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 54. Bio-Rad Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 55. ArcherDX Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 56. ARUP Laboratories Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 57. Asuragen Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 58. Invivoscribe Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 59. Adaptive Biotechnologies Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 60. Amoy Diagnostics Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 61. ELITechGroup Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 62. Vela Diagnostics Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 63. Gentronix Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 64. BioIVT Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 65. SAGA Diagnostics Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 66. Berry Genomics Revenue Growth Rate in Hematology Oncology Diagnostics Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
